Cargando…
PM512. The effectiveness of clozapine in reducing medical costs associated with treatment-resistant schizophrenia in Japanese patients
Autor principal: | Kikuchi, Yuka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616445/ http://dx.doi.org/10.1093/ijnp/pyw041.512 |
Ejemplares similares
-
Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia
por: Kikuchi, Yuka Sugawara, et al.
Publicado: (2019) -
PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016) -
PM422. Creatine Phospho Kinase Elevations with Clozapine
por: Takahashi, Yuka
Publicado: (2016) -
PM420. Additional clinical effects of long-term clozapine therapy for chronic schizophrenia
por: Seo, Young Eun, et al.
Publicado: (2016) -
PM381. Reason for clozapine discontinuation
por: Cho, Jin-Woo, et al.
Publicado: (2016)